Supermoon Capital

Supermoon Capital is a pioneering venture capital firm exclusively focused on the rapidly growing sleep industry, which they refer to as the "Night Market™." Launched in 2021 with a $36 million fund, Supermoon Capital seeks to address the global epidemic of insufficient sleep, which affects 75% of Americans and has been declared a public health crisis by the CDC. The firm invests in early-stage startups across various sectors, including software, medical devices, and consumer products, all aimed at improving sleep health through science-backed innovations. The firm’s portfolio is diverse, featuring companies like Endel, an AI-driven platform that creates personalized soundscapes to enhance sleep and reduce stress, and EnsoData, which uses FDA-cleared AI software to assist clinicians in diagnosing sleep disorders like sleep apnea. Other notable investments include FreshBed, a Netherlands-based company that designs beds optimizing air quality, temperature, and humidity for better sleep, and Clair Labs, an Israeli startup revolutionizing patient monitoring with contact-free technology for clinical-grade physiological monitoring. Supermoon Capital was co-founded by industry veterans Pat Connolly, Michael Masterson, and Grayson Judge. Connolly, with his extensive background at Williams-Sonoma, brings a wealth of experience in business strategy and e-commerce. Masterson and Judge contribute deep expertise from the healthcare and venture capital sectors. Together, they provide more than just capital; they offer a robust network of sleep science experts and strategic partners to help their portfolio companies succeed. Supermoon Capital is positioned as the premier source of expertise and funding in the emerging sleep economy.